Related by context. Frequent words. (Click for all words.) 60 Announces Adjournment 59 Therapeutic Competitors 58 Idera Pharmaceuticals develops 58 Biomagnetics Diagnostics Corporation 58 PETAQUILLA MINERALS LTD 58 Completes Patient Enrollment 57 Corp. Nasdaq GENZ 57 Presents Positive 57 Crucell NV NYSE Euronext 57 Inc Therapeutic Competitors 57 Vern Brownell founder 56 Holds Annual Meeting 56 Initiates Phase II 56 Dr. Sidransky 55 Sets Annual Meeting 55 Directors Elects 55 ICOS Corporation 55 Alexander Denner 55 Enrolls First 55 Takeda Kyowa Hakko Kirin 55 Nasdaq CRXL 55 FREE Whitepaper 54 Sign License Agreement 54 Co BMY 54 ® bortezomib 54 please visit www.eisai.com 54 Hubert Yoshida vice 54 Inc. Nasdaq ELGX 54 Idec Roche 54 Urges Shareholders 54 Idera Pharmaceuticals 54 Other ImmunoGen collaborative 54 By STEVE CAMPBELL 54 Exploit collaboration 54 Inc. NASDAQ RRGB 54 Therapeutic Competitors Report 54 A. Pontius 54 Receives Orphan Drug Designation 53 Astex Therapeutics 53 OTCBB NEOP diversified 53 Shareholders Elect 53 staphylococcal vaccines 52 Unveils Enhanced 52 Meritech Capital 52 Nominating Corporate Governance 52 Completes Enrollment 52 www.sorin.com 52 using BioSante patented 52 Prism Pharmaceuticals 52 Agios Pharmaceuticals 51 include bioavailability enhancement 51 imaging neurodegenerative disorders 51 R sorafenib tablets 51 PRNewswire FirstCall Accuray Incorporated 51 Develop Novel 51 NeoPhotonics Corporation 51 Meets Primary Endpoint 51 GlaxoSmithKline Bristol Myers 51 oncology immunology 51 Locus Pharmaceuticals 51 hospitals physicians homecare 51 Geekzone ® SohoSolutions 51 leading lipid nanoparticle 51 Genentech GlaxoSmithKline 51 James A. Mitarotonda 51 commercializes biotherapeutics 50 By OnMilwaukee.com Staff 50 Stockholders Vote 50 Fresenius Kabi AG 50 Taiho Pharmaceutical 50 By Katie Klingsporn 50 Announces FDA Clearance 50 Inc. NASDAQ ETRM 50 AstraZeneca Bristol Myers 50 NV Organon 50 oncolytic virus therapies 50 http:/www.biolase.com 50 Fidelity Biosciences 50 Bayhill Therapeutics 50 sanofi aventis GlaxoSmithKline 50 BY DEAN CRIDDLE 50 BioMarin develops 50 Barrington Broadcasting FOX 50 Receives Positive Opinion 50 Kensey Nash Corporation 50 Vytorin combines 50 including nutritionals devices 49 3G WCDMA HSDPA 49 PFE PFE 49 Alberto Cribiore 49 Synergetics USA 49 markets therapeutic ultrasonic 49 PricewaterhouseCoopers Oy 49 By Bob Grotenhuis 49 Vasomedical Inc. 49 immunologic diseases 49 Quark Pharmaceuticals 49 non personalized allogeneic 49 David Helwig 49 ophthalmics 49 Barrington Broadcasting WACH